14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

NCT ID: NCT02737618

Last Updated: 2017-09-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermal Irritation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy subject

Healthy subjects exposed to Trojan "Chameleon" Personal Lubricant applied by occlusive patch

Group Type EXPERIMENTAL

Trojan "Chameleon" Personal Lubricant

Intervention Type DEVICE

silicone base with sensate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trojan "Chameleon" Personal Lubricant

silicone base with sensate

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male or female, 18-70 years of age, in general good health
* normal skin
* free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events
* of any skin type or race providing the skin pigmentation will allow discernment of erythema
* agree to complete a medical history and concomitant medication form
* read, understand and sign informed consent

Exclusion Criteria

* have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation
* are receiving systemic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results
* have psoriasis and/or active atopic dermatitis/eczema
* have a known sensitivity to cosmetics, skin care test articles, or topical drugs as related to the test article being evaluated
* are females who are pregnant or breastfeeding or become pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Church & Dwight Company, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John Dosik, MD

Role: PRINCIPAL_INVESTIGATOR

TKL Research, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

TKL Research Inc

Fair Lawn, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ST-7611

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Experimental Human Rhinovirus Infection
NCT01823640 COMPLETED PHASE1
Home Screening for Chlamydia Surveillance
NCT00177437 COMPLETED PHASE3